Palmero Iii, Bernardo R.

HRN: 27-87-12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2025
CEFUROXIME 750MG (VIAL)
09/28/2025
10/05/2025
IV
340mg
Q8H
PCAP C
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: